Vectors based on the DNA viruses, adenoviruses, and adeno-associated virus (AAV), have shown promise for in vivo gene transfer. Adenoviral vectors have been the mainstay for experimental and clinical application of in vivo gene transfer. The efficiency of gene transfer has been high with adenoviruses; however, problems of vector instability and vibrant immune response have limited their utility. Attempts to further disable recombinant adenoviruses have shown promise in overcoming some of these limitations. More recently, AAV has shown promise for efficient, stable, and safe application to muscle and liver-directed gene transfer. It appears AAV can evade problematic immune response to the transgene product. In addition, interesting data have emerged regarding the potential utility of adenoviruses fully deleted of all open reading frames. This P01 application will build on the known biology of AAV and fully deleted adenoviruses to a variety of targets relevant to cardiovascular diseases. Project 1 by Dr. James Wilson will study the biology of transduction and immunology of AAV in the context of liver and muscle. More focused studies will be performed with fully deleted adenoviral vectors. Information gained from Project 1 will be transferred to disease- based applications in Projects 2 and 3. Dr. Lee Sweeney (Project 2) will use gene transfer to target cells to cardiac muscle. He will study the pathogenesis of family hypertrophic cardiomyopathy and develop genetic treatments for inherited and acquired cardiomyopathy Dr. Rader (Project 3) will evaluate the consequence of apoprotein expression in atherosclerosis using the vectors developed in Project 1. Data emerging from Projects 2 and 3 will feedback to the basic vector biology performed in Project 1. Two existing cores of the Institute for Human Gene Therapy, the Vector Core and Cell Morphology will support work in the three projects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL059407-05
Application #
6637492
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Skarlatos, Sonia
Project Start
1999-03-01
Project End
2004-06-30
Budget Start
2003-03-01
Budget End
2004-06-30
Support Year
5
Fiscal Year
2003
Total Cost
$1,395,686
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Giles, April R; Govindasamy, Lakshmanan; Somanathan, Suryanarayan et al. (2018) Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors. J Virol 92:
Amengual, Jaume; Guo, Liang; Strong, Alanna et al. (2018) Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100. Circ Res 122:568-582
Giles, April R; Sims, Joshua J; Turner, Kevin B et al. (2018) Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function. Mol Ther 26:2848-2862
Calcedo, Roberto; Somanathan, Suryanarayan; Qin, Qiuyue et al. (2017) Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for ?-1-antitrypsin deficiency. Proc Natl Acad Sci U S A 114:1655-1659
Ai, Jianzhong; Li, Jia; Gessler, Dominic J et al. (2017) Adeno-associated virus serotype rh.10 displays strong muscle tropism following intraperitoneal delivery. Sci Rep 7:40336
Ai, Jianzhong; Tai, Phillip W L; Lu, Yi et al. (2017) Characterization of adenoviral transduction profile in prostate cancer cells and normal prostate tissue. Prostate 77:1265-1270
Greig, Jenny A; Limberis, Maria P; Bell, Peter et al. (2017) Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR+/- Rhesus Macaques. Hum Gene Ther Clin Dev 28:39-50
Greig, Jenny A; Limberis, Maria P; Bell, Peter et al. (2017) Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia. Hum Gene Ther Clin Dev 28:28-38
Ajufo, Ezim; Cuchel, Marina (2016) Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia. Curr Atheroscler Rep 18:22
Ibrahim, Salam; Somanathan, Suryanarayan; Billheimer, Jeffrey et al. (2016) Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol. Cardiovasc Res 110:23-9

Showing the most recent 10 out of 149 publications